Inventor
BELL LESLIE D
US15 patents
⚠️ This page may combine multiple inventors who share the name “BELL LESLIE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
10 patentsUS4935233AJun 19, 1990
Covalently linked polypeptide cell modulators
SEARLE & CO768 citations98
US5114711AMay 19, 1992
Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates
SEARLE & CO108 citations96
US4753795AJun 28, 1988
Modified (80-113) beta interferons
SEARLE & CO32 citations96
US4914033AApr 3, 1990
Structure and properties of modified interferons
SEARLE & CO64 citations95
US4738844AApr 19, 1988
Modified (1-28) beta interferons
SEARLE & CO29 citations92
US4769233ASep 6, 1988
Structure and properties of modified interferons
SEARLE & CO39 citations91
US4751077AJun 14, 1988
Interferons with novel cysteine pattern
SEARLE & CO36 citations91
US4793995ADec 27, 1988
Modified (1-56) beta interferons
SEARLE & CO24 citations81
US4738845AApr 19, 1988
Modified (115-145) beta interferons
SEARLE & CO9 citations73
US4719180AJan 12, 1988
Synthetic urogastrone gene, corresponding plasmid recombinants, transformed cells, production thereof and urgastrone expression
SEARLE & CO5 citations57
MONSANTO CO
5 patentsUS6130333AOct 10, 2000
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
MONSANTO CO39 citations88
US5244676ASep 14, 1993
Modified tissue plasminogen activator with modified glycosylation site
MONSANTO CO2 citations59
US5100666AMar 31, 1992
Modified tissue plasminogen activator K2K2SP
MONSANTO CO2 citations59
US5037752AAug 6, 1991
Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
MONSANTO CO5 citations59
US4963357AOct 16, 1990
Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
MONSANTO CO5 citations59